NFE2L2 and colorectal cancer: In this context, NRF2 inhibition leads to the upregulation of miR-181a-2-3p, which directly targets HIF-2α, consequently resulting in the attenuation of the HIF-2α-mediated CSC phenotype in colorectal cancer cells (Fig. 2c)66.